Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Treatment preferences in juvenile idiopathic arthritis - a comparative analysis in two health care systems.

Hugle B, Haas JP, Benseler SM.

Pediatr Rheumatol Online J. 2013 Jan 15;11(1):3. doi: 10.1186/1546-0096-11-3.

2.

Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they?

Butbul YA, Tyrrell PN, Schneider R, Dhillon S, Feldman BM, Laxer RM, Saurenmann RK, Spiegel L, Cameron B, Tse SM, Silverman ED.

J Rheumatol. 2009 Sep;36(9):2033-41. doi: 10.3899/jrheum.080674.

PMID:
19648305
3.
4.

Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis.

Ringold S, Weiss PF, Colbert RA, DeWitt EM, Lee T, Onel K, Prahalad S, Schneider R, Shenoi S, Vehe RK, Kimura Y; Juvenile Idiopathic Arthritis Research Committee of the Childhood Arthritis and Rheumatology Research Alliance..

Arthritis Care Res (Hoboken). 2014 Jul;66(7):1063-72. doi: 10.1002/acr.22259.

5.

Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.

Zink A, Listing J, Ziemer S, Zeidler H; German Collaborative Arthritis Centres..

J Rheumatol. 2001 Oct;28(10):2201-8.

PMID:
11669156
6.

Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.

Ravelli A, Felici E, Magni-Manzoni S, Pistorio A, Novarini C, Bozzola E, Viola S, Martini A.

Arthritis Rheum. 2005 Mar;52(3):826-32.

7.

Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).

Davies R, Carrasco R, Foster HE, Baildam EM, Chieng SE, Davidson JE, Ioannou Y, Wedderburn LR, Thomson W, Hyrich KL.

Semin Arthritis Rheum. 2016 Oct;46(2):190-5. doi: 10.1016/j.semarthrit.2016.06.001.

8.

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.

Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, Schmeling H; German and Austrian Paediatric Rheumatology Collaborative Study Group..

Ann Rheum Dis. 2009 Apr;68(4):519-25. doi: 10.1136/ard.2007.087593.

PMID:
18413440
9.

Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.

Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.

J Rheumatol. 2004 Sep;31(9):1829-33.

PMID:
15338508
10.

Articular damage in adults with juvenile idiopathic arthritis.

Gurcay E, Eksioglu E, Yuzer S, Bal A, Cakci A.

Rheumatol Int. 2009 Apr;29(6):635-40. doi: 10.1007/s00296-008-0740-3.

PMID:
18853165
11.

[Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database].

Heiligenhaus A, Niewerth M, Mingels A, Ganser G, Thon A, Pleyer U, Greiner K, Minden K.

Klin Monbl Augenheilkd. 2005 Dec;222(12):993-1001. German.

PMID:
16418970
12.

Epidemiology of juvenile idiopathic arthritis in Alsace, France.

Danner S, Sordet C, Terzic J, Donato L, Velten M, Fischbach M, Sibilia J.

J Rheumatol. 2006 Jul;33(7):1377-81.

PMID:
16821272
13.

Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis.

Tsitsami E, Bozzola E, Magni-Manzoni S, Viola S, Pistorio A, Ruperto N, Martini A, Ravelli A.

Arthritis Rheum. 2003 Aug 15;49(4):488-93.

14.

Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.

Tynjälä P, Vähäsalo P, Tarkiainen M, Kröger L, Aalto K, Malin M, Putto-Laurila A, Honkanen V, Lahdenne P.

Ann Rheum Dis. 2011 Sep;70(9):1605-12. doi: 10.1136/ard.2010.143347.

PMID:
21623000
15.

Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort.

Oen K, Duffy CM, Tse SM, Ramsey S, Ellsworth J, Chédeville G, Chetaille AL, Saint-Cyr C, Cabral DA, Spiegel LR, Schneider R, Lang B, Huber AM, Dancey P, Silverman E, Rosenberg AM, Cameron B, Johnson N, Dorval J, Scuccimarri R, Campillo S, Petty RE, Duffy KN, Boire G, Haddad E, Houghton K, Laxer R, Turvey SE, Miettunen P, Gross K, Guzman J, Benseler S, Feldman BM, Espinosa V, Yeung RS, Tucker L.

Arthritis Care Res (Hoboken). 2010 Apr;62(4):527-36. doi: 10.1002/acr.20044.

16.

Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.

Fautrel B, Guillemin F, Meyer O, de Bandt M, Berthelot JM, Flipo RM, Lioté F, Maillefert JF, Wendling D, Saraux A, Combe B, Le Loët X; Stratégies Thérapeutiques dans La Polyarthrite RhumatoIde Working Group.; Club Rhumatismes et Inflammation.; French Society of Rheumatology..

Arthritis Rheum. 2009 Apr 15;61(4):425-34. doi: 10.1002/art.24588.

17.
18.
19.

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.

Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Koné-Paut I, Gandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debré M, Landais P, Prieur AM.

Arthritis Rheum. 2003 Apr;48(4):1093-101.

20.

Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis.

Felici E, Novarini C, Magni-Manzoni S, Pistorio A, Magnani A, Bozzola E, Buoncompagni A, Martini A, Ravelli A.

J Rheumatol. 2005 Sep;32(9):1805-10.

PMID:
16142881
Items per page

Supplemental Content

Support Center